Innoviva (INVA) Free Cash Flow (QoQ) (2010 - 2025)
Innoviva (INVA) Free Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Innoviva | 1.60 Bn | 998.03 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 220.60% |
| Jun 30, 2025 | -9.35% |
| Sep 30, 2024 | 195.49% |
| Jun 30, 2024 | 18.01% |
| Sep 30, 2023 | 181.67% |
| Jun 30, 2023 | 48.85% |
| Sep 30, 2022 | 143.98% |
| Jun 30, 2022 | -19.44% |
| Sep 30, 2021 | 213.70% |
| Jun 30, 2021 | 0.60% |
| Mar 31, 2021 | -1.38% |
| Dec 31, 2020 | 14.38% |
| Sep 30, 2020 | -6.56% |
| Jun 30, 2020 | 8.61% |
| Mar 31, 2020 | 9.83% |
| Dec 31, 2019 | 16.53% |
| Sep 30, 2019 | 1.60% |
| Jun 30, 2019 | -26.30% |
| Mar 31, 2019 | 24.08% |
| Dec 31, 2018 | 2.76% |